Tag Archives | Orphan drugs

Biotech Bear Market: But It Is Time to Start Trading…11/9 Updates on Rally

see Update at Close 11/9/18 Remain Cautious as Rally Fails The NASDAQ down 1.6% and Russell 2000 down 1.8%, sold off killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. The healthcare still looks good overall with the XLV down only 0.29% at $92.95. The XBI was crushed again down […]

Continue Reading 0

Biotech Momentum Lost Mired in Macro-Economic News Cycle: China, FED,Trade etc.

http://paterson-associates.co.uk/property/suite-b-2-water-lane/ Biotech Momentum Lost Technical Breakdown: XBI Near April Bottom but XLV Looks Good Market Looking for Growth from Large Cap Earnings 10 year auction has tepid demand at Yield of 3.225%, NASDAQ at 7602 own 1.75% (Prices as of mid-day 1:30 p EDT) Biotech momentum losses were triggered by a reversal in investor psychology  because […]

Continue Reading 0

Biotech Bounces to Trend Line-Clinical News Lifts Stocks…Update ALXN, TSRO

buy provigil online ireland Update 9/26: FED Rate Hike Curbs Traders but Biotech Rolls On The market dipped slightly then went red about 3:30P EDT resulting in a 0.4% loss for the Dow. Main rates will rise to the 2 to 2.25% level with more rate hikes in the future. During Trump’s Press Conference today he said he does not […]

Continue Reading 0

Biotechs Bounce Back, Dow and S&P Hit New Highs

Biotechs Bounce Back: Up From September Lows-Markets Surge Ahead XBI Up 1.66% to $97.16 up from 3 month tech support of $95;IBB up 1.39%. Broad  rally brings Dow up 1%, S&P up 0.81% to fresh highs-strong 4 mo. trend line. Sector Winners: Tech (XLK) up 1.18%, Materials (XLB) up 1.08%, Healthcare (XLV) new high up […]

Continue Reading 0

Biotech Weakens Further: September Down 5% -Updates ABBV GWPH TSRO

Update 9/19 : Lightened up on Abbvie (ABBV) in low 90s with news of CA lawsuit on Humira kickbacks. Amgen (AMGN) hits 52 week high in $204 range, strong hold up 14.9% YTD. GW Pharmaceuticals (GWPH) rallies 6.61% to $159 for second day on cannabis trading frenzy; up 18.7% YTD with market cap $4.5B vs […]

Continue Reading 0

Rayno Biopharma Portfolio Movers: AMGN TSRO…Updates

9/16 The Week That Was: September Trending Down for Biotech NASDAQ-100 Holding (QQQ) at 184 up 1.7% last week. Large caps all weak on Friday; key will be Q3 earnings. FBT, IBB and XBI flat for the week; off highs reached 8/31/18. Mid-caps more mixed with strength in ICPT LGND NBIX NVCR RARE SGEN Healthcare […]

Continue Reading 0

Biotech Weakness but why Large Caps?…Updates

Update: 10:10a Tesaro (TSRO) Soars 15% to $38, short covering or bargain hunters? News item: expansion of Zejula Combo Trial in NSCLC ========= Biotech Weakness in Large Caps Mid-Caps Have Continued Strength The overall market recovered from an early sell-off but there was pronounced biotech weakness as well as in healthcare stocks one of the […]

Continue Reading 0

IBB Hits 2018 High but FBT is Still the Leading ETF over 5 Years: CAR-T, RNAi …Updates

8/30/18 Weak Rally to another Round of Highs Curbed by more Tough Tariff Threats This week’s rally and uber bullish sentiment was slowed by Tough Talk about $200B in new tariffs next week. Other news from Trump on Google, Facebook and Amazon threatening antitrust action curbed buyers at mid-day. FBT to $157.43 at new highs […]

Continue Reading 0

Biotechs Cruise onto Green Screen: July Looks Good…Updates

Updates: 7/19 pm… Abbvie (ABBV) takes a 4.7% hit on Citron short seller call. Basis for call would be pressure from FDA and Scott Gottlieb concerning stalling by drug companies on biosimilars. Many reports cite biosimilar risk to blockbuster Humira. Merck succumbs to Trump pricing pressure with a minor Hep-C drug. Mid-caps mainly green, large caps […]

Continue Reading 0

2018 Biotech Sector Watch on Earnings #1: AMGN,BIIB…Updates

Update 4/25: Investors May See Value in Large Cap Biotech Amgen (AMGN) up 1.68%. Biogen (BIIB) holds Tuesday lows of $262 Up 2.78% today. IBB flat at $103.26 More earnings tomorrow but it is all about technicals holding the recent bottom. ========== Biotech Sector Watch on 2018 Earnings Interest Rates at 3% Rising Too Fast? […]

Continue Reading 0